Abstract
Nature is the finest physician: it takes care of everyone because its concerns are universal and genuine; however, it always follows certain guidelines and principles and scientists can learn from these. Giving birth is an act of nature through which the realm of creation is opened to the mother. Nature comes from the Latin word Natus, “to be born.” During birth, if nothing is present, what will prevent infection from affecting the newly born baby? Nature’s concern can be seen when the vagina is washed, prior to birth, by a fine baby-friendly liquid containing cell suspension and antibacterial elements, which gives it a disinfectant property; it also possesses lubricant and cell therapy properties that are crucial for the mother and the child at the critical time of birth. This fluid is known as the amniotic fluid. So far, no one appears to have used this fluid for any therapeutic purpose for more than 70 years in the practice of modern medicine. However, there has been some recent awareness about amniotic fluid as a source of mesenchymal stem cells, which can be converted into any cell type given the niche or the environment for its transdifferentiation property, the implication being that it can help in regeneration in a degenerating system.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Johnson HL. Observation on the prevention of post operative peritonitis and abdominal adhesions. Surg Gynac Obstet. 1927;XLV:612.
Johnson HL. An exposition and the preparation and administration of the amniotic fluid concentrate. N Engl J Med. 1935;CCXII:557.
Jones ES. Joint lubrication. Lancet. 1936;1:1043.
Lacey JT. Amniotic fluid - A clinical study. Ann Surg. 1935;Cl:529.
Collins DH. The pathology of sinovial effusions. J Pathol Bacteriol. 1936;XLII:113.
Mandell S. The use of amniotic fluid concentrate on orthopedic conditions. J Bone Joint Surg Am. 1938;20:167-177.
Leung VY, Chan D, Cheung KM. Regeneration of intervertebral disc by mesenchymal stem cells: potentials, limitations, and future direction. Eur Spine J. 2006;15(suppl 3):S406-413.
Sobajima S, Vadala G, Shimer A, Kim JS, Gilbertson LG, Kang JD. Feasibility of a stem cell therapy for intervertebral disc degeneration. Spine J. 2008;8(6):888-896.
Kaviani A, Perry TE, Dzakovic A, Jennings RW, Ziegler MM, Fauza DO. The amniotic fluid as a source of cells for fetal tissue engineering. J Pediatr Surg. 2001;36(11):1662-1665.
Prusa AR, Hengstschlager M. Amniotic fluid cells and human stem cell research: a new connection. Med Sci Monitor. 2002;8(11):RA253-257.
Medina-Gomez P, del Valle M (1988) Cultivo de celas de liquido amniotico. Analisis de colonias, metafases e indice mitotico, con fin de descartar contaminacion de celulas maternas. Ginecol Obstet Mex. 56122–1
In’t Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood. 2003;102(4):1548-1549.
Prusa AR, Marton E, Rosner M, et al. Neurogenic cells in human amniotic fluid. Am J Obstet Gynecol. 2004;191(1):309-314.
Ref: Royal College of General Practitioners. Morbidity Statistics from General Practice 1991–92. London, U.K.: HMSO; 1995.
McAlindon TE, Cooper C, Kirwan JR, Dieppe P. Determinants of disability in osteoarthritis of the knee. Ann Rheum Dis. 1993;52:258-262.
Sjögren P, Halling A. Quality of reporting randomised clinical trials in dental and medical research. Br Dental J. 2002;192:100-103.
Jadad AR. Randomised Controlled Trials. London, U.K.: BMJ Books; 1998:28-36.
O’Donoghue K, Choolani M, Chan J, et al. Identification of fetal mesenchymal stem cells in maternal blood: implications for non-invasive prenatal diagnosis. Mol Hum Reprod. 2003;9:497-502.
O’Donoghue K, Chan J, de La Fuente J, et al. Microchimerism in female bone marrow and bone decades after fetal mesenchymal stem-cell trafficking in pregnancy. Lancet. 2004;364:179-182.
Perin L, Giuliani S, Jin D, et al. Renal differentiation of amniotic fluid stem cells. Cell Prolif. 2007;40(6):936-948.
Friedman DM, Moore ME. The efficacy of intraarticular steroids in osteoarthritis: a double-blind study. J Rheumatol. 1980;7:850-856.
Mazieres B, Masquelier AM, Capron MH. A French controlled multicenter study of ntraarticular orgotein versus intraarticular corticosteroids in the treatment of knee osteoarthritis: a one-year follow up. J Rheumatol Suppl. 1991;27:134-137.
Cederlof S, Jonson G. Intraarticular prednisolone injection for osteoarthritis of the knee. A double blind test with placebo. Acta Chir Scand. 1966;132:532-537.
Dieppe PA, Sathapatayavongs B, Jones HE, Bacon PA, Ring EF. Intra-articular steroids in osteoarthritis. Rheumatol Rehabil. 1980;19:212-217.
Raynauld J, Buckland-Wright C, Ward R, et al. Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee. Arth Rheum. 2003;48:370-377.
American College of Rheumatology subcommittee on osteoarthritis guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee. Arth Rheum. 2000;43:1905-1915.
Ayral X. Injections in the treatment of osteoarthritis. Best Pract Res Clin Rehumatol. 2001;15:609-626.
Gaffney K, Ledingham J, Perry JD. Intra-articular triamcinolone hexacetonide in kneeosteoarthritis: factors influencing the clinical response. Ann Rheumat Dis. 1995;54:379-381.
Acknowledgment
The Department of Science and Technology, Government of West Bengal supported the investigator with a research grant during his tenure at Bijoygarh State Hospital from 1999 to 2006.The work started in Bijoygarh Government Hospital (1999–2006) and was followed up at Vidyasagore Government Hospital subsequently. The author gratefully acknowledges the support of the patients who volunteered for this research work. Guidance of Prof K. L. Mukherjee of Biochemistry and Prof M. K. Chhetri, former Director of Health Services and Prof B. K. Dutta of Orthopaedics are also acknowledged.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer London
About this chapter
Cite this chapter
Bhattacharya, N. (2011). Clinical Use of Amniotic Fluid in Osteoarthritis: A Source of Cell Therapy. In: Bhattacharya, N., Stubblefield, P. (eds) Regenerative Medicine Using Pregnancy-Specific Biological Substances. Springer, London. https://doi.org/10.1007/978-1-84882-718-9_38
Download citation
DOI: https://doi.org/10.1007/978-1-84882-718-9_38
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-84882-717-2
Online ISBN: 978-1-84882-718-9
eBook Packages: MedicineMedicine (R0)